Scientific Industries (SCND) director awarded 140,000 stock options as fees

Rhea-AI Filing Summary

Scientific Industries Inc. director John J. Nicols received stock options as compensation instead of cash fees. On February 17, 2026, he was granted stock options covering a total of 140,000 shares of Common Stock, with an exercise price of $0.60 per share and an expiration date of February 17, 2036.

The options vest over one year at a rate of 1/12 per month. Following these awards, Nicols holds 275,778 stock options in total, reflecting routine equity-based director compensation rather than open‑market trading.

Insights

Equity compensation analyst

Director received routine option grants as equity fees, not market trades.

John J. Nicols, a director of Scientific Industries Inc., was granted stock options for 140,000 underlying Common shares at an exercise price of $0.60 per share. The grant is explicitly described as being in lieu of cash fees, indicating standard non-cash board compensation.

The options vest over one year, 1/12 per month, aligning with typical service-based vesting. After the grants, Nicols holds 275,778 stock options, suggesting this filing reflects ongoing compensation rather than a change in his economic exposure through open-market buying or selling.

Because these are option awards with a 2036 expiration and no immediate cash transaction, the near-term impact on existing shareholders mainly relates to potential future dilution, which would depend on whether the options are eventually exercised at or above the $0.60 strike price.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

NICOLS JOHN J

(Last) (First) (Middle)

ALBEMARLE CORP

451 FLORIDA ST

(Street)

BATON ROUGE LA 70801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SCIENTIFIC INDUSTRIES INC [ SCND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$0.6	02/17/2026	02/17/2026	A		120,000		02/17/2027(1)	02/17/2036	Common Stock	120,000	$0	255,778	D
Stock Option	$0.6	02/17/2026	02/17/2026	A		20,000		02/17/2027(1)	02/17/2036	Common Stock	20,000	$0	275,778	D

Explanation of Responses:

1. On 2/17/26 Registrant was awarded stock options in lieu of cash fees. Vesting 1 Year - 1/12th per month.

	John Nicols	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Scientific Industries (SCND) report for John J. Nicols?

Scientific Industries reported that director John J. Nicols received stock option grants covering 140,000 shares of Common Stock. The options were awarded as compensation in lieu of cash fees, not through open-market buying or selling of existing shares.

How many stock options did SCND director John J. Nicols receive?

John J. Nicols received stock option grants for a total of 140,000 underlying Common shares. One grant covered 120,000 shares and a second covered 20,000 shares, both at the same exercise price and on the same grant date.

What is the exercise price and term of the new SCND stock options?

The options granted to John J. Nicols have an exercise price of $0.60 per share and expire on February 17, 2036. This long-dated term gives him a multi‑year window to exercise if the stock trades above the strike price.

How do the new option grants affect John J. Nicols’ total SCND holdings?

After these option awards, John J. Nicols holds 275,778 stock options related to Scientific Industries common shares. The filing shows an increase from prior levels, reflecting additional equity-based compensation rather than a reduction in his position.

How do the SCND options granted to John J. Nicols vest?

The options granted to John J. Nicols vest over one year, with 1/12 of the award vesting each month. This schedule ties his equity compensation to ongoing board service across the full year following the February 17, 2026 grant date.

Were the SCND stock options granted to John J. Nicols in cash or equity form?

The options were explicitly awarded in lieu of cash fees, meaning Nicols received equity compensation instead of cash payments for his director service. This aligns his incentives with shareholder value by linking compensation to the company’s share performance.